Arthritis Shoulder
0
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
MedactaSwitzerland - Castel San Pietro
1 programMirror Medacta Shoulder SystemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
Nordic PharmaTornier Ascend Flex stem
MedactaMirror Medacta Shoulder System
Clinical Trials (2)
Total enrollment: 119 patients across 2 trials
Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty
Start: Oct 2023Est. completion: Nov 202519 patients
N/ATerminated
Mirror Medacta Shoulder System Pivotal Trial
Start: Jan 2022Est. completion: Dec 2027100 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 119 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.